MENU
+Compare
RMD
Stock ticker: NYSE
AS OF
Sep 3 closing price
Price
$269.21
Change
-$1.78 (-0.66%)
Capitalization
39.42B

RMD ResMed Forecast, Technical & Fundamental Analysis

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more

RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RMD with price predictions
Sep 02, 2025

RMD's Stochastic Oscillator remains in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RMD advanced for three days, in of 343 cases, the price rose further within the following month. The odds of a continued upward trend are .

RMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 314 cases where RMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RMD moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RMD as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RMD turned negative on August 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.605) is normal, around the industry mean (10.842). P/E Ratio (28.308) is within average values for comparable stocks, (58.755). Projected Growth (PEG Ratio) (1.813) is also within normal values, averaging (1.717). Dividend Yield (0.008) settles around the average of (0.016) among similar stocks. P/S Ratio (7.708) is also within normal values, averaging (38.564).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RMD is expected to report earnings to fall 1.18% to $2.52 per share on October 23

ResMed RMD Stock Earnings Reports
Q3'25
Est.
$2.52
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.11
Q3'24
Beat
by $0.15
The last earnings report on July 31 showed earnings per share of $2.55, beating the estimate of $2.48. With 1.80M shares outstanding, the current market capitalization sits at 39.42B.
A.I.Advisor
published Dividends

RMD is expected to pay dividends on September 18, 2025

ResMed RMD Stock Dividends
A dividend of $0.60 per share will be paid with a record date of September 18, 2025, and an ex-dividend date of August 14, 2025. The last dividend of $0.53 was paid on June 12. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of devices for evaluation and treatment of sleep disorders

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UUP27.550.18
+0.66%
Invesco DB US Dollar Bullish
SMBS25.33-0.06
-0.24%
Schwab® Mortgage-Backed Securities ETF
LGOV21.40-0.07
-0.33%
First Trust Long Duration Opp ETF
BSR29.17-0.12
-0.40%
Beacon Selective Risk ETF
AVUS105.46-0.67
-0.63%
Avantis US Equity ETF

RMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-1.28%
SOLV - RMD
46%
Loosely correlated
-1.74%
RVTY - RMD
42%
Loosely correlated
-2.49%
IDXX - RMD
41%
Loosely correlated
-1.18%
SYK - RMD
39%
Loosely correlated
-0.38%
NVST - RMD
37%
Loosely correlated
-2.17%
More

Groups containing RMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-1.28%
Pharmaceuticals
category (389 stocks)
36%
Loosely correlated
-0.23%
Pharmaceuticals: Other
category (104 stocks)
32%
Poorly correlated
-0.69%